jRCT2080225139已完成1 期
Phase1 Study of TS-141 in Healthy Volunteers
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 48
- 试验地点
- 1
- 主要终点
- pharmacokinetics
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Open-label, single/multiple-ascending dose Study
- 主要目的
- Treatment Purpose
入排标准
- 年龄范围
- 20age old over 至 39age old under（—）
- 性别
- Male
入选标准
- •Healthy Volunteers
排除标准
- •Patients with a current medical history or medical history deemed inappropriate for participation in this study
结局指标
主要结局
pharmacokinetics
To investigate Pharmacokinetics parameter of TS-141 and its metabolite
incidence of Treatment-emergent Adverse Events and Serious AEs, vital-sign, weight, 12-leads ECG and clinical laboratory test
To investigate incidence of Treatment-emergent Adverse Events and Serious AEs, vital-sign, weight, 12-leads ECG and clinical laboratory test
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Phase1 Study of TS-141 in Healthy Volunteers-JPRN-jRCT2080225139Taisho Pharmaceutical Co.Ltd48
未知
1 期
Phase 1 Clinical Study of TS-071 in Healthy Adult Male Subjects (Single-Dose Administration)Healthy Japanese male subjectsJPRN-jRCT2080222304Taisho Pharmaceutical co., LTD57
未知
1 期
Phase 1 Clinical Study of TS-071 in Healthy Male Adults (Repeated Administration)Healthy Japanese male subjectsJPRN-jRCT2080222305Taisho Pharmaceutical co., LTD24
已完成
不适用
A phase I study of TS-172 in healthy adult subjects (Single and Multiple doses)jRCT2071210043Taisho Pharmaceutical Co., LTD.41
已完成
1 期
A phase I study of TS-172 in healthy adult subjects (Single and Multiple doses)Healthy adult subjectsJPRN-jRCT2071210043Mita Seiji41